Single and Repeated Dose Escalation Study of GSK2838232

Clinical trial NCT02795754 · COMPLETED

Trial details

NCT number: NCT02795754
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2016-03-01
Primary completion: 2016-12-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.